Published in Int J Nanomedicine on July 22, 2011
Preparation, in vitro and in vivo evaluation of mPEG-PLGA nanoparticles co-loaded with syringopicroside and hydroxytyrosol. J Mater Sci Mater Med (2015) 0.76
GX1-conjugated poly(lactic acid) nanoparticles encapsulating Endostar for improved in vivo anticolorectal cancer treatment. Int J Nanomedicine (2015) 0.76
The Challenges of Recombinant Endostatin in Clinical Application: Focus on the Different Expression Systems and Molecular Bioengineering. Adv Pharm Bull (2017) 0.75
Nanocarriers as an emerging platform for cancer therapy. Nat Nanotechnol (2007) 17.80
Regulation of transport pathways in tumor vessels: role of tumor type and microenvironment. Proc Natl Acad Sci U S A (1998) 7.78
Strategies in the design of nanoparticles for therapeutic applications. Nat Rev Drug Discov (2010) 7.48
The manufacturing techniques of various drug loaded biodegradable poly(lactide-co-glycolide) (PLGA) devices. Biomaterials (2000) 4.42
Stealth liposomes and long circulating nanoparticles: critical issues in pharmacokinetics, opsonization and protein-binding properties. Prog Lipid Res (2003) 3.89
Controlled delivery systems for proteins based on poly(lactic/glycolic acid) microspheres. Pharm Res (1991) 2.70
Nanoparticles evading the reticuloendothelial system: role of the supported bilayer. Biochim Biophys Acta (2009) 1.94
Targeting nanoparticles to cancer. Pharmacol Res (2010) 1.88
Polymer degradation and in vitro release of a model protein from poly(D,L-lactide-co-glycolide) nano- and microparticles. J Control Release (2003) 1.72
Endostar, a novel recombinant human endostatin, exerts antiangiogenic effect via blocking VEGF-induced tyrosine phosphorylation of KDR/Flk-1 of endothelial cells. Biochem Biophys Res Commun (2007) 1.69
Continuous administration of endostatin by intraperitoneally implanted osmotic pump improves the efficacy and potency of therapy in a mouse xenograft tumor model. Cancer Res (2001) 1.55
Factors affecting the degradation rate of poly(lactide-co-glycolide) microspheres in vivo and in vitro. Biomaterials (1999) 1.50
Phase I pharmacokinetic and pharmacodynamic study of recombinant human endostatin in patients with advanced solid tumors. J Clin Oncol (2003) 1.33
Recent developments in liposomes, microparticles and nanoparticles for protein and peptide drug delivery. Peptides (2009) 1.24
Nanotechnology for targeted cancer therapy. Expert Rev Anticancer Ther (2007) 1.21
Preparation, characterization and in-vitro evaluation of sustained release protein-loaded nanoparticles based on biodegradable polymers. Int J Nanomedicine (2008) 1.20
A multicenter, randomized, double-blind, placebo-controlled study to evaluate the efficacy of paclitaxel-carboplatin alone or with endostar for advanced non-small cell lung cancer. J Thorac Oncol (2011) 1.19
Endostatin inhibits tumour lymphangiogenesis and lymphatic metastasis via cell surface nucleolin on lymphangiogenic endothelial cells. J Pathol (2010) 1.06
Pharmacokinetics of His-tag recombinant human endostatin in Rhesus monkeys. Acta Pharmacol Sin (2005) 1.03
Poly(ethylene glycol)-block-polyethylenimine copolymers as carriers for gene delivery: effects of PEG molecular weight and PEGylation degree. J Biomed Mater Res A (2008) 1.02
Development and characterization of CyA-loaded poly(lactic acid)-poly(ethylene glycol)PEG micro- and nanoparticles. Comparison with conventional PLA particulate carriers. Eur J Pharm Biopharm (2001) 1.01
All-trans-retinoic acid release from core-shell type nanoparticles of poly(epsilon-caprolactone)/poly(ethylene glycol) diblock copolymer. Int J Pharm (2004) 0.96
Endostar-loaded PEG-PLGA nanoparticles: in vitro and in vivo evaluation. Int J Nanomedicine (2010) 0.92
N-terminal modification increases the stability of the recombinant human endostatin in vitro. Biotechnol Appl Biochem (2009) 0.89
Combined chemo-immunotherapy as a prospective strategy to combat cancer: a nanoparticle based approach. Mol Pharm (2010) 0.88
Phase II study of cisplatin/etoposide and endostar for extensive-stage small-cell lung cancer. Cancer Chemother Pharmacol (2011) 0.87
Optimizing drug delivery for enhancing therapeutic efficacy of recombinant human endostatin in cancer treatment. Crit Rev Ther Drug Carrier Syst (2007) 0.86
Characterization of a monoPEG20000-Endostar. Int J Biol Macromol (2010) 0.82
Clinical pharmacology of methadone in dogs. Vet Anaesth Analg (2010) 0.81
Effect of three different injection sites on the pharmacokinetics of the once-daily human GLP-1 analogue liraglutide. J Clin Pharmacol (2010) 0.80
Microspheres made by w/o/o emulsion method with reduced initial burst for long-term delivery of endostar, a novel recombinant human endostatin. J Pharm Sci (2009) 0.79
Continuous versus intermittent administration of human endostatin in xenografted human neuroblastoma. J Pediatr Surg (2003) 0.79
Sustained delivery of endostatin improves the efficacy of therapy in Lewis lung cancer model. J Control Release (2008) 0.79
Effect of medium-chain triglycerides on the release behavior of Endostar encapsulated PLGA microspheres. Int J Pharm (2010) 0.77
Increased CD4(+) CD69(+) CD25(-) T cells in patients with hepatocellular carcinoma are associated with tumor progression. J Gastroenterol Hepatol (2011) 1.57
CEACAM1 cytoplastic expression is closely related to tumor angiogenesis and poorer relapse-free survival after curative resection of hepatocellular carcinoma. World J Surg (2011) 1.42
Therapeutic management of hemorrhage from visceral artery pseudoaneurysms after pancreatic surgery. J Gastrointest Surg (2011) 1.07
Gasless laparoendoscopic single-site surgery with abdominal wall lift in general surgery: initial experience. Surg Endosc (2010) 1.00
A randomized clinical trial of laparoscopic Roux-en-Y gastric bypass and sleeve gastrectomy for the treatment of morbid obesity in China: a 5-year outcome. Obes Surg (2014) 0.97
Sleeve gastrectomy provides a better control of diabetes by decreasing ghrelin in the diabetic Goto-Kakizaki rats. J Gastrointest Surg (2009) 0.97
SMYD3 as an oncogenic driver in prostate cancer by stimulation of androgen receptor transcription. J Natl Cancer Inst (2013) 0.96
Role of AIB1 for tamoxifen resistance in estrogen receptor-positive breast cancer cells. Oncology (2008) 0.95
TERT promoter mutations in renal cell carcinomas and upper tract urothelial carcinomas. Oncotarget (2014) 0.94
Clinical application of a laparoscope in ventri-peritoneal shunting. Minim Invasive Ther Allied Technol (2007) 0.93
Prognostic value of nuclear β-catenin overexpression at invasive front in colorectal cancer for synchronous liver metastasis. Ann Surg Oncol (2011) 0.89
Endovascular stent-graft placement and coil embolization for an anomalous splenic artery aneurysm. J Vasc Surg (2011) 0.85
Spontaneous retroperitoneal hematoma associated with iliac vein rupture. J Vasc Surg (2010) 0.85
The entire small intestine mediates the changes in glucose homeostasis after intestinal surgery in Goto-Kakizaki rats. Ann Surg (2012) 0.84
High expression of CCL20 is associated with poor prognosis in patients with hepatocellular carcinoma after curative resection. J Gastrointest Surg (2011) 0.84
Laparoscopic proctocolectomy with ileal pouch-anal anastomosis. Surg Laparosc Endosc Percutan Tech (2007) 0.81
Endoscopic thyroidectomy: the development in a Chinese center. J Laparoendosc Adv Surg Tech A (2011) 0.81
Laparoscopic versus open proctocolectomy with ileal pouch-anal anastomosis. Minim Invasive Ther Allied Technol (2007) 0.81
Therapeutic management of superior mesenteric artery aneurysms. J Vasc Surg (2011) 0.80
Endoscopy Lithotomy for Intrahepatic Gallstones: A Meta-Analysis. Surg Laparosc Endosc Percutan Tech (2015) 0.78
Activation of telomerase by seminal plasma in malignant and normal cervical epithelial cells. J Pathol (2011) 0.78
Analysis of risk factors for postoperative complication of repair of bile duct injury after laparoscopic cholecystectomy. Dig Dis Sci (2014) 0.77
Myocardial insulin signaling and glucose transport are up-regulated in Goto-Kakizaki type 2 diabetic rats after ileal transposition. Obes Surg (2012) 0.77
The correlation between sonographic diagnosis and laparoscopic observations on fatty liver. J Laparoendosc Adv Surg Tech A (2009) 0.77
Expedited Biliopancreatic Juice Flow to the Distal Gut Benefits the Diabetes Control After Duodenal-Jejunal Bypass. Obes Surg (2015) 0.77
Retracted Microwave ablation with cooled-tip electrode for liver cancer: an analysis of 160 cases. Minim Invasive Ther Allied Technol (2008) 0.77
Effects of CO2 insufflation on cerebrum during endoscopic thyroidectomy in a porcine model. Surg Endosc (2010) 0.77
Duodenal-jejunal bypass surgery up-regulates the expression of the hepatic insulin signaling proteins and the key regulatory enzymes of intestinal gluconeogenesis in diabetic Goto-Kakizaki rats. Obes Surg (2013) 0.77
The changes of pro-opiomelanocortin neurons in type 2 diabetes mellitus rats after ileal transposition: the role of POMC neurons. J Gastrointest Surg (2011) 0.77
Sub-sleeve gastrectomy achieves good diabetes control without weight loss in a non-obese diabetic rat model. Surg Endosc (2013) 0.77
Type 2 diabetes control in a nonobese rat model using sleeve gastrectomy with duodenal-jejunal bypass (SGDJB). Obes Surg (2012) 0.77
Microwave ablation with cooled-tip electrode for liver cancer: an analysis of 160 cases. Hepatogastroenterology (2009) 0.76
Duodenal-jejunal bypass surgery suppresses hepatic de novo lipogenesis and alleviates liver fat accumulation in a diabetic rat model. Obes Surg (2014) 0.76
Duodenal-jejunal bypass improves glucose metabolism and adipokine expression independently of weight loss in a diabetic rat model. Obes Surg (2013) 0.76
Association between age and synchronous liver metastasis in female colorectal cancer patients. J Cancer Res Clin Oncol (2010) 0.75
Timing of Cholecystectomy for Biliary Pancreatitis in Chinese Patients. Surg Laparosc Endosc Percutan Tech (2015) 0.75
Influence of the time of hepatocyte infusion on liver transplantation outcome. Hepatogastroenterology (2014) 0.75
[Role and mechanism of duodenal-jejunal bypass in the management of type 2 diabetes mellitus]. Zhonghua Wei Chang Wai Ke Za Zhi (2014) 0.75
Endovascular stent graft repair of a penetrating aortic injury. Ann Thorac Surg (2010) 0.75
Duodenal-Jejunal bypass improves glucose homeostasis in association with decreased proinflammatory response and activation of JNK in the liver and adipose tissue in a T2DM rat model. Obes Surg (2014) 0.75
Extended pancreatectomy with en bloc resection of the celiac axis for locally advanced cancer of pancreatic body and tail. Hepatogastroenterology (2009) 0.75
Single-step versus 2-step management of huge pancreatic pseudocysts: a prospective randomized trial with long-term follow-up. Pancreas (2015) 0.75
Endovascular stent-graft placement for retrograde type A aortic dissection. J Vasc Interv Radiol (2011) 0.75
Would pancreas duct-epithelium-derived stem/progenitor cells enhance islet allograft survival by means of islets recruitment and tolerance induction in Edmonton protocol era? Med Hypotheses (2007) 0.75